Compare AU

Compare DRUG vs. MVW

Compare shares and ETFs on the ASX that you can trade on Pearler.

BetaShares Global Healthcare ETF - Currency Hedged

ASX

Buy

Buy

Overview
Performance

Overview

When it comes to investing in the Australian stock market, Exchange-Traded Funds (ETFs) are a popular choice. Two well-known options in the Australian Securities Exchange (ASX) are the BetaShares Global Healthcare ETF - Currency Hedged (DRUG) and the Aussie Large-Caps (equal weight) (MVW). In this comparison, we'll delve into these ETFs across various dimensions to help you make an informed investment decision.

Community Stats

DRUG

MVW

Popularity

Low

Low

Pearlers invested

63

252

Median incremental investment

$967.00

$828.50

Median investment frequency

Monthly

Monthly

Median total investment

$1,921.92

$3,850.65

Average age group

26 - 35

> 35


Key Summary

DRUG

MVW

Strategy

DRUG.AX was created on 2016-08-04 by BetaShares. The fund's investment portfolio concentrates primarily on health care equity. DRUG.AX aims to track the performance of an index (before fees and expenses) that comprises the largest global healthcare companies (ex-Australia), hedged into Australian dollars.

The fund seeks to track the performance of the MVIS Australia Equal Weight Index before additional fees.

Top 3 holdings

CHF - SWISS FRANC (0 %)

AUD - AUSTRALIA DOLLAR (0 %)

DKK - DANISH KRONE (0 %)

Arcadium Lithium PLC CDI (2.81 %)

Pro Medicus Ltd (2.04 %)

Qantas Airways Ltd (1.66 %)

Top 3 industries

Other (75.53 %)

Communication Services (33.53 %)

Health Care (24.47 %)

Real Estate (39.46 %)

Industrials (18.36 %)

Materials (17.99 %)

Top 3 countries

United States (71.71 %)

Switzerland (8.14 %)

Denmark (6.30 %)

Australia (97.03 %)

United States (2.97 %)

Management fee

0.57 %

0.35 %


Key Summary

DRUG

MVW

Issuer

BetaShares

VanEck

Tracking index

Nasdaq Global ex-Australia Healthcare Hedged AUD Index - AUD

MVIS Australia Equal Weight Index - AUD

Asset class

ETF

ETF

Management fee

0.57 %

0.35 %

Price

$8.25

$38.38

Size

$182.401 million

$2.613 billion

10Y return

N/A

89.25 %

Annual distribution yield (5Y)

1.90 %

4.53 %

Market

ASX

ASX

First listed date

08/08/2016

06/03/2014

Purchase fee

$6.50

$6.50


Community Stats

DRUG

MVW

Popularity

Low

Low

Pearlers invested

63

252

Median incremental investment

$967.00

$828.50

Median investment frequency

Monthly

Monthly

Median total investment

$1,921.92

$3,850.65

Average age group

26 - 35

> 35


Pros and Cons

DRUG

MVW

Pros

  • Higher exposure to US market

  • Higher price growth

  • Higher exposure to AU market

  • Lower management fee

  • Higher distribution yield

Cons

  • Lower exposure to AU market

  • Higher management fee

  • Lower distribution yield

  • Lower exposure to US market

  • Lower price growth

DRUG

MVW

Lower exposure to AU market

Higher exposure to AU market

Higher exposure to US market

Lower exposure to US market

Higher management fee

Lower management fee

Higher price growth

Lower price growth

Lower distribution yield

Higher distribution yield

Home